Cover Image
市場調查報告書

愛滋病相關卡波西氏肉瘤:開發平台分析

AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015

出版商 Global Markets Direct 商品編碼 229760
出版日期 內容資訊 英文 57 Pages
訂單完成後即時交付
價格
Back to Top
愛滋病相關卡波西氏肉瘤:開發平台分析 AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015
出版日期: 2015年07月22日 內容資訊: 英文 57 Pages
簡介

卡波西氏肉瘤是由淋巴管和血管細胞發病的癌症。一般會在皮膚表面和粘膜表面(口腔內等)出現腫瘤,但腫瘤也可能轉移到其他部位,譬如淋巴節(豆粒大的免疫細胞的集節)和消化管。卡波西氏肉瘤是HIV感染過程中最常見的惡性腫瘤。如果在肺,肝臟,消化管發生病變,會造成嚴重症狀,有危及生命的可能。

本報告提供愛滋病相關卡波西氏肉瘤的治療藥開發情形調查分析,提供您開發中產品的概要,臨床實驗的各階段產品概要,主要企業簡介,藥物簡介,開發中產品的最新趨勢,最新消息和新聞稿等相關的系統性資訊。

目錄

簡介

愛滋病相關卡波西氏肉瘤概要

治療藥的開發

  • 開發中產品:概要
  • 開發中產品:比較分析

企業開發中的治療藥

開發中產品概況

  • 臨床階段的產品
  • 初期階段的產品
  • 開發階段不明的產品

企業開發中的產品

治療藥的開發企業

  • Aphios Corporation
  • AstraZeneca Plc
  • Biogenomics Limited
  • CytRx Corporation

治療藥的評估

  • 單劑產品
  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

藥物簡介

  • aldoxorubicin hydrochloride
  • CS-TATI-1
  • interferon alfa-2a (recombinant)
  • interferon alfa-2b (recombinant)
  • paclitaxel nanosomal
  • selumetinib sulfate

最新開發平台趨勢

暫停中的計劃

暫停中的計劃

開發中止的產品

產品開發的里程碑

  • 主要消息和新聞稿

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC6925IDB

Summary

Global Markets Direct's, 'AIDS - Related Kaposi's Sarcoma - Pipeline Review, H2 2015', provides an overview of the AIDS - Related Kaposi's Sarcoma's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for AIDS - Related Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for AIDS - Related Kaposi's Sarcoma and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of AIDS - Related Kaposi's Sarcoma
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for AIDS - Related Kaposi's Sarcoma and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the AIDS - Related Kaposi's Sarcoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the AIDS - Related Kaposi's Sarcoma pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products

Reasons to buy

  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for AIDS - Related Kaposi's Sarcoma
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding AIDS - Related Kaposi's Sarcoma pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • AIDS - Related Kaposi's Sarcoma Overview
  • Therapeutics Development
    • Pipeline Products for AIDS - Related Kaposi's Sarcoma - Overview
    • Pipeline Products for AIDS - Related Kaposi's Sarcoma - Comparative Analysis
  • AIDS - Related Kaposi's Sarcoma - Therapeutics under Development by Companies
  • AIDS - Related Kaposi's Sarcoma - Pipeline Products Glance
    • Clinical Stage Products
    • Early Stage Products
    • Unknown Stage Products
  • AIDS - Related Kaposi's Sarcoma - Products under Development by Companies
  • AIDS - Related Kaposi's Sarcoma - Companies Involved in Therapeutics Development
    • Aphios Corporation
    • AstraZeneca Plc
    • Biogenomics Limited
    • CytRx Corporation
  • AIDS - Related Kaposi's Sarcoma - Therapeutics Assessment
    • Assessment by Monotherapy Products
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Drug Profiles
    • aldoxorubicin hydrochloride - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • CS-TATI-1 - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • interferon alfa-2a (recombinant) - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • interferon alfa-2b (recombinant) - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • paclitaxel nanosomal - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • selumetinib sulfate - Drug Profile
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • AIDS - Related Kaposi's Sarcoma - Recent Pipeline Updates
  • AIDS - Related Kaposi's Sarcoma - Dormant Projects
  • AIDS - Related Kaposi's Sarcoma - Dormant Projects
  • AIDS - Related Kaposi's Sarcoma - Discontinued Products
  • AIDS - Related Kaposi's Sarcoma - Product Development Milestones
    • Featured News & Press Releases
      • Jan 08, 2015: CytRx Announces Positive Interim Phase 2 Aldoxorubicin Results as a Treatment for HIV-Related Kaposi's Sarcoma
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H2 2015
  • Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Development, H2 2015
  • Comparative Analysis by Unknown Stage Development, H2 2015
  • Products under Development by Companies, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Pipeline by Aphios Corporation, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Pipeline by AstraZeneca Plc, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Pipeline by Biogenomics Limited, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Pipeline by CytRx Corporation, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Number of Products by Stage and Target, H2 2015
  • Number of Products by Stage and Mechanism of Action, H2 2015
  • Number of Products by Stage and Route of Administration, H2 2015
  • Number of Products by Stage and Molecule Type, H2 2015
  • AIDS - Related Kaposi's Sarcoma Therapeutics - Recent Pipeline Updates, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Dormant Projects, H2 2015
  • AIDS - Related Kaposi's Sarcoma - Discontinued Products, H2 2015

List of Figures

  • Number of Products under Development for AIDS - Related Kaposi's Sarcoma, H2 2015
  • Number of Products under Development for AIDS - Related Kaposi's Sarcoma - Comparative Analysis, H2 2015
  • Number of Products under Development by Companies, H2 2015
  • Comparative Analysis by Clinical Stage Development, H2 2015
  • Comparative Analysis by Early Stage Products, H2 2015
  • Assessment by Monotherapy Products, H2 2015
  • Number of Products by Top 10 Targets, H2 2015
  • Number of Products by Stage and Top 10 Targets, H2 2015
  • Number of Products by Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2015
  • Number of Products by Top 10 Routes of Administration, H2 2015
  • Number of Products by Stage and Top 10 Routes of Administration, H2 2015
  • Number of Products by Top 10 Molecule Types, H2 2015
  • Number of Products by Stage and Top 10 Molecule Types, H2 2015
Back to Top